alprenolol has been researched along with hydralazine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (82.35) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Sivertsson, R | 1 |
| Fauchald, P; Pape, JF; Talseth, T | 1 |
| Fauchald, P; Pape, JF; Pytte, R | 1 |
| Kornerup, HJ; Pedersen, EB | 2 |
| Mogensen, CE; Pedersen, EB | 1 |
| Christensen, NJ; Pedersen, EB | 1 |
| Erikssen, J; Storm-Mathisen, H | 1 |
| De Schaepdryver, AF; Lambelin, G; Roba, J | 1 |
| Pape, J | 2 |
| Comerford, MB; Pringle, A | 1 |
| Johnsson, G | 1 |
| Johnsson, G; Sannerstedt, R; Stenberg, J; Werkö, L | 1 |
6 trial(s) available for alprenolol and hydralazine
| Article | Year |
|---|---|
Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
Topics: Adult; Alprenolol; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Time Factors | 1977 |
[Long-term treatment of essential hypertension with hydralazine and alprenolol].
Topics: Alprenolol; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Time Factors | 1978 |
[Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
Topics: Adult; Alprenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Placebos | 1973 |
A long-term study of the antihypertensive effect of alprenolol.
Topics: Adult; Aged; Alprenolol; Blood Pressure Determination; Chlorthalidone; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Male; Middle Aged; Placebos; Posture; Propranolol; Time Factors | 1974 |
The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
Topics: Adult; Alprenolol; Blood Pressure; Blood Pressure Determination; Clinical Trials as Topic; Delayed-Action Preparations; Depression, Chemical; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Placebos; Time Factors | 1974 |
Alprenolol in hypertension.
Topics: Aged; Alprenolol; Benzothiadiazines; Chlorthalidone; Clinical Trials as Topic; Digitalis; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Hypertension; Methyldopa; Phytotherapy; Placebos; Plants, Medicinal; Plants, Toxic; Sodium Chloride Symporter Inhibitors; Time Factors | 1974 |
11 other study(ies) available for alprenolol and hydralazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Peripheral haemodynamics in essential hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Humans; Hydralazine; Hypertension; Mefruside; Pressoreceptors; Propranolol; Vascular Resistance; Vasomotor System | 1977 |
Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
Topics: Adult; Alprenolol; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Renin | 1977 |
Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension.
Topics: Aged; Albuminuria; Alprenolol; Animals; Blood Pressure; Female; Glomerular Filtration Rate; Guinea Pigs; Humans; Hydralazine; Hypertension; Kidney; Male; Middle Aged; Regional Blood Flow | 1976 |
Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques.
Topics: Adult; Age Factors; Aged; Alprenolol; Dopamine; Drug Therapy, Combination; Epinephrine; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Norepinephrine | 1975 |
Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.
Topics: Adult; Aged; Alprenolol; Depression, Chemical; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypertension, Renal; Male; Middle Aged; Renin | 1975 |
[Beta-blockaders in hypertension].
Topics: Adrenergic beta-Antagonists; Alprenolol; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Propranolol | 1973 |
Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Disease Models, Animal; Heart Rate; Hydralazine; Hypertension; Male; Propranolol; Rats; Sotalol | 1972 |
Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man.
Topics: Adult; Alprenolol; Cardiac Output; Cardiac Volume; Drug Interactions; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypertension; Male; Middle Aged; Receptors, Adrenergic; Vascular Resistance | 1971 |